Lara D. Veeken · 1999 · 62 citations · 4 references
MedicineImmunologyInternal MedicineAutoimmunityMonoclonal AntibodiesRheumatologyAutoimmune DiseasesAutoimmune Rheumatic DiseasesInflammatory ArthritisJoint DiseaseJoint PathologyRheumatoid ArthritisAnti-cd20 Antibody TherapyAnti-cd20 TherapyAutoimmune SynovitisChronic SynovitisImmune-mediated ArthritisRheumatoid Arthritis PharmacotherapyRheumatoid Arthritis TherapyRheumatologic Disease Management
We describe a case involving a 53-yr-old male with a marginal zone B-cell lymphoma, associated with an IgM paraprotein and a rheumatoid factor-negative inflammatory polyarthropathy, treated with monoclonal anti-CD20 antibody. During the subsequent 12 weeks, evidence of synovitis reduced to a negligible level, despite no significant change in lymphoma bulk or paraprotein level. The relationship between the lymphoma and the arthropathy, and the likely mechanism of remission of the arthropathy, are discussed in the context of the potential value of anti-CD20 therapy in rheumatoid arthritis.
4
Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20
ME Reff, K Carner, KS Chambers et al. · Blood · 1994 · 1.9K citations · Full text
Life Sciences, Immunology, Pathology +14
Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20
ME Reff, K Carner, KS Chambers et al. · Blood · 1994 · 202 citations
Life Sciences, Immunology, Pathology +14